SWGHFOTCHealthcare · Drug Manufacturers - Specialty & Generic

Sawai Group Holdings Co., Ltd.

$11.52+0.00%(+$0.00)

TickerSpark Score

59/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SWGHF research report →

52-Week Range50% of range

Low $11.52

Current $11.52

High $11.52

Companywww.sawaigroup.holdings

Sawai Group Holdings Co. , Ltd. , together with subsidiaries, engages in the research, development, manufacturing, and marketing of generic pharmaceutical products primarily in Japan and the United States.

CEO: Mitsuo Sawai
IPO: 2021
Employees: 3,482
HQ: Osaka, JP

Price Chart

+0.00% · this period

Valuation

Market Cap: $1.33B
P/E: 19.43
P/S: 1.01
P/B: 1.14
EV/EBITDA: 9.95
Div Yield: 3.13%

Profitability

Gross Margin: 29.15%
Op Margin: 10.01%
Net Margin: 5.18%
ROE: 5.88%
ROIC: 5.56%

Growth & Income

Revenue: $202.95B · 7.36%
Net Income: $10.50B · -54.21%
EPS: $91.07 · -50.78%
Op Income: $20.48B
FCF YoY: -1886.55%

Performance & Tape

52W High: $11.52
52W Low: $11.52
50D MA: $11.52
200D MA: $11.52
Beta: 0.09
Avg Volume: 55.92

Get TickerSpark's AI analysis on SWGHF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime